Nevertheless, the anti-cancer mechanism involving Beclin1 knockdown, in context with reports indicating the cancer-promoting activities of miR-221/222, further adds to the complex role of miR-221/222 in ER+ breast cancer promotion and inhibition. Here, BECN1 is linked to breast cancer.